Eligibility criteria
Condition
Complete Remission in Renal Cell Carcinoma
Sex
Females and Males
Age
18-99 years
Inclusion criteria
Show details
- Patients with metastatic renal cell carcinoma, histopathologically confirmed
- Treated with sunitinib according to Smpc
- For cases: Achieving a CR (local assessment according to RECIST V1.0 criteria) with
Sunitinib in prior 6 months alone OR in combination with local treatment (surgery,
radiation therapy, ablative techniques: cryotherapy, RFA)
- For controls: Life expectancy > 3 months No prior Sunitinib treatment
- Patient >18 years
Exclusion criteria
Show details
- Sunitinib administered in a non-approved label
- For cases: CR occurring without sunitinib treatment
- For controls: Prior systemic treatment